This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Otten N. COX-2 inhibitors: a role in colorectal cancer? Ottawa: Canadian Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologies de la Sante (CCOHTA) 1999: 4
Authors' objectives
To summarise the available evidence on the use of COX-2 inhibitors in the treatment or prevention of colorectal cancer.
Authors' conclusions
The use of ASA or NSAIDs is not recommended for the prevention of colorectal cancer as there is insufficient high quality evidence of its benefit despite numerous epidemiological and laboratory studies.